Disturbing new evidence: Antidepressant use that substantially increases the risk of sudden cardiac death

(NaturalHealth365)  Antidepressants are among the most widely prescribed medications in the world.  Millions of people take them for years, sometimes decades, under the assumption that long-term use is both “effective and safe.”  Doctors rarely revisit the decision once a prescription is in place.

Now, two major findings are forcing a reckoning with that assumption.  A June 2026 peer-reviewed overview in the Australian Journal of General Practice found that the benefits of long-term antidepressant use have been systematically overstated.  In fact, a separate Danish population study of 4.3 million people found that long-term use dramatically raises the risk of sudden cardiac death.

Flawed antidepressant research has kept millions of people on medication for too long

Researchers from Adelaide University and the University of Queensland reviewed the evidence behind long-term antidepressant prescribing and found a fundamental problem.  Most relapse prevention trials compare patients who continue medication against those who stop abruptly.  Because abrupt stopping produces withdrawal symptoms that closely mirror depression, those studies have been systematically miscounting withdrawal as relapse.

The researchers concluded that many apparent relapses may actually be withdrawal effects, not a return of depression.  Short-term trials also show only small differences between antidepressants and a placebo.  Nearly one in seven Australians now takes antidepressants.  A third stay on them for more than a year, often without any review of whether the drug is still warranted.

The cardiac risk that patients are not being told about

While evidence for long-term benefit weakens under scrutiny, evidence for long-term harm has grown considerably.  Researchers at Rigshospitalet in Copenhagen analyzed all deaths among 4.3 million Danish residents.

Among 643,999 people with prior antidepressant exposure, those using antidepressants for one to five years faced a 56% higher risk of sudden cardiac death.  Those who took antidepressants for six or more years faced more than double the risk compared with the general population.

The age-specific findings are stark.  Among people aged 30 to 39, six or more years of use raised the risk of sudden cardiac death fivefold.

Among those aged 50 to 59, six or more years quadrupled the risk.  The researchers adjusted for age, sex, and existing health conditions, and the pattern held across every age group studied.

Why long-term use strains the heart and the whole body

Antidepressants affect electrical signaling in the heart, a mechanism well documented in cardiac research.  Prolonged use can alter rhythm regulation in ways that raise vulnerability to arrhythmia.  Many antidepressants also deplete magnesium over time, which governs cardiac electrical stability, and CoQ10, which powers energy production in heart muscle cells.

Beyond cardiac effects, the Adelaide researchers noted that long-term use is associated with cognitive impairment, emotional numbing, weight gain, and sexual dysfunction.  Withdrawal after long-term use can be severe and persistent, sometimes lasting months or years.  Many patients find stopping so difficult that they remain on medication indefinitely, never knowing whether they still need the drug.

What people on antidepressants deserve to know right now

Demand a formal review of any antidepressant prescription in place for more than a year.  The Adelaide researchers specifically called for treatment reviews every six months.

Research makes clear that most people recover from depression without long-term medication.  The risks of extended use accumulate silently while prescriptions renew automatically.

Address the nutrient depletions that long-term antidepressant use drives.  Extended use depletes magnesium and B vitamins, both of which are essential for cardiac rhythm and neurological function.  Magnesium supports cardiac electrical stability and mitigates some of the cardiovascular effects documented in the Danish data.

B vitamins support the mood-regulating pathways that may eventually allow lower medication needs.

Build the biological foundations that reduce dependence on pharmaceutical management.  Research consistently shows that omega-3 fatty acids, physical activity, and meaningful social connections reduce depression through mechanisms that carry no cardiac risk.

Adaptogenic herbs such as ashwagandha reduce cortisol and support nervous system resilience.  Of course, working with a knowledgeable practitioner to reassess medication needs alongside these strategies gives the body a genuine path forward.

The cardiac warning buried inside one of the world’s most prescribed drugs

Millions of people refilling antidepressant prescriptions this month have no idea what the long-term cardiac data now show.  Jonathan Landsman’s Cardiovascular Docu-Class brings together 22 scientists, researchers, doctors, and nutritionists to cover cardiovascular risk factors that routine appointments consistently miss, including the hidden ways in which pharmaceutical drugs cause nutrient deficiencies and how chronic stress can damage the heart over the years.

Discover functional lab tests that identify heart risk before symptoms appear, natural protocols for supporting cardiac electrical stability, and the nutritional strategies that address root causes that no prescription was designed to reach.

Click here to own the Cardiovascular Docu-Class.

Sources for this article include:

Racgp.org.au
Eurekalert.org
Eurekalert.org

The post Disturbing new evidence: Antidepressant use that substantially increases the risk of sudden cardiac death appeared first on NaturalHealth365.

Visit Natural Health 365 Here /